MedPath

Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event

Not Applicable
Completed
Conditions
Skin Cancer
Telemedicine
Screening
Interventions
Other: In-person dermatology evaluation
Other: Store-and-forward teledermatology evaluation
Registration Number
NCT01820234
Lead Sponsor
University of California, Davis
Brief Summary

The purpose of this study is to determine the diagnostic and management concordance of face-to-face dermatologist versus a store-and-forward teledermatologist at a skin cancer screening event.

The investigators' hypotheses include the following:

1. Compared to in-person assessment, store-and-forward teledermatology assessment will result in adequate diagnostic concordance.

2. Compared to in-person assessment, store-and-forward teledermatology results in adequate management concordance.

3. The sensitivity and specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant will be similar to that of in-person evaluation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
170
Inclusion Criteria
  • 18 years of age or older at time of consent, may be male or female.
  • Able to provide a brief medical history and have/allow an examination of their skin including photographs.
  • Capable of giving informed consent.
  • Will be able to receive notification of follow-up recommendations
Exclusion Criteria
  • Patients who will not provide informed consent
  • Patient who are unable to fulfill tasks of this study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
In-person dermatology evaluationIn-person dermatology evaluationHealth care modality
Store-and-forward teledermatology evaluationStore-and-forward teledermatology evaluationHealth care modality
Primary Outcome Measures
NameTimeMethod
Aggregated diagnostic concordanceAt the time of dermatologist evaluation (Day 1)

Aggregated diagnostic concordance which is defined as the agreement of the in-person dermatologist's principle diagnosis with the teledermatologist's primary diagnosis or any of the differential diagnoses.

Secondary Outcome Measures
NameTimeMethod
Primary diagnostic concordanceAt the time of dermatologist evaluation (Day 1)

Diagnostic concordance between the in-person dermatologist and the teledermatologist for their primary diagnosis.

Categorical diagnostic concordanceAt the time of dermatologist evaluation (Day 1)

Diagnostic concordance between the in-person dermatologist and teledermatologist based on standard clinical diagnostic categories for each lesion.

Management concordanceAt the time of dermatologist evaluation (Day 1)

The concordance between the in-person dermatologist and teledermatologist for the chosen management plan for each lesion.

SensitivityAt the time of dermatologist evaluation (Day 1)

The sensitivity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant.

SpecificityAt the time of dermatologist evaluation (Day 1)

The specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant.

Trial Locations

Locations (1)

University of California, Davis Shifa Community Clinic

🇺🇸

Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath